Based on the Tekla Healthcare Opportunities stock forecast from 0 analysts, the average analyst target price for Tekla Healthcare Opportunities is not available over the next 12 months. Tekla Healthcare Opportunities’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Tekla Healthcare Opportunities is Very Bullish, which is based on 3 positive signals and 0 negative signals. At the last closing, Tekla Healthcare Opportunities’s stock price was USD 19.36. Tekla Healthcare Opportunities’s stock price has changed by +2.06% over the past week, -1.33% over the past month and +2.71% over the last year.
No recent analyst target price found for Tekla Healthcare Opportunities
No recent average analyst rating found for Tekla Healthcare Opportunities
Company Overview Tekla Healthcare Opportunities
Tekla Healthcare Opportunities Fund is a closed ended balanced mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity and fixed income markets across the globe. It seeks to invest in securities of companies operating in the healthcare sector. The fund also invests in pooled investment vehicles. For its fixed income portion, the fund invests in corporate debt securities across the credit rating spectrum. It benchmarks the performance of its portfolio against the S&P 1500 Healthcare Index and S&P 500 Index. Tekla Healthcare Opportunities Fund was formed on April 2, 2014 and is domiciled in the United States. Read Less
Tekla Healthcare Opportunities Fund is a closed ended balanced mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity and fixed income markets across the globe. It seeks to invest in securities of companies operating in the healthcare ...Read More
Frequently Asked Questions About Tekla Healthcare Opportunities (THQ) Stock
Stock Target Advisor's fundamental analysis for Tekla Healthcare Opportunities's stock is Very Bullish.
THQ stock's dividend yield is 9.27%.
Our analysis grades THQ stock's dividend yield at D+. This means that THQ stock's dividend yield is above 67% of the stocks in the Asset Management sector in the NYE exchange.
Based on this THQ may be a average dividend stock for its sector.
Unfortunately we do not have enough data on THQ's stock to indicate what its average analyst target is.
THQ stock's Price/Earning ratio is 6.90.
Our analysis grades THQ stock's Price / Earning ratio at C+. This means that THQ stock's Price/Earning ratio is above 22% of the stocks in the Asset Management sector in the NYE exchange.
Based on this THQ may be undervalued for its sector.
The last closing price of THQ's stock was USD 19.36.
The most recent market capitalization for THQ is USD 0.64B.
Unfortunately we do not have enough analyst data on THQ's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Tekla Healthcare Opportunities's stock.
As per our most recent records Tekla Healthcare Opportunities has 0 Employees.
Tekla Healthcare Opportunities's registered address is 100 Federal Street, Boston, MA, United States, 02110.
You can get more information about it from Tekla Healthcare Opportunities's website at http://www.teklacap.com/thq.html.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
High dividend returns
The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.
What not to like
There is nothing we particularly dislike
Frequently Asked Questions About Tekla Healthcare Opportunities (THQ) Stock
Stock Target Advisor's fundamental analysis for Tekla Healthcare Opportunities's stock is Very Bullish.
THQ stock's dividend yield is 9.27%.
Our analysis grades THQ stock's dividend yield at D+. This means that THQ stock's dividend yield is above 67% of the stocks in the Asset Management sector in the NYE exchange.
Based on this THQ may be a average dividend stock for its sector.
Unfortunately we do not have enough data on THQ's stock to indicate what its average analyst target is.
THQ stock's Price/Earning ratio is 6.90.
Our analysis grades THQ stock's Price / Earning ratio at C+. This means that THQ stock's Price/Earning ratio is above 22% of the stocks in the Asset Management sector in the NYE exchange.
Based on this THQ may be undervalued for its sector.
The last closing price of THQ's stock was USD 19.36.
The most recent market capitalization for THQ is USD 0.64B.
Unfortunately we do not have enough analyst data on THQ's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Tekla Healthcare Opportunities's stock.
As per our most recent records Tekla Healthcare Opportunities has 0 Employees.
Tekla Healthcare Opportunities's registered address is 100 Federal Street, Boston, MA, United States, 02110.
You can get more information about it from Tekla Healthcare Opportunities's website at http://www.teklacap.com/thq.html.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for THQ !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
